Retraction
miR-217-5p inhibits invasion and metastasis of prostate cancer by targeting clusterin
Paper Information
Record ID:
45535
Author(s):
Journal:
Publication Date:
May 15, 2021
Retraction Date:
June 19, 2023
(2.4 years years ago)
Subjects:
Institutions:
- Department of Urology, The Third Hospital of Hebei Medical University, No. 139 Ziqiang Road, Shijiazhuang, 050001, Hebei, China
- Second Department of Urology, Cangzhou Central Hospital, No. 16, Xinhua West Road, Cangzhou, 061001, Hebei, China
- Department of Anesthesiology, The Third Hospital of Hebei Medical University, No. 139, Ziqiang Road, Shijiazhuang, 050001, Hebei, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Springer
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (14)
14
Total Citations4
Post-Retraction(28.6%)
10
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
4
Within 1 year
0
After 2+ years
296
Days since retraction (latest)
Therapeutic Potential of Clusterin Inhibition in Human Cancer
Desirée Martín‐García, Marilina García-Aranda, Maximino Redondo
Cells
Open Access
Published: Apr 2024
1 citation
1 citation
296 days after retraction
miRNome expression analysis in canine diffuse large B-cell lymphoma
Nelly O. Elshafie, Michael Gribskov, Nathanael I. Lichti et al. (6 authors)
Frontiers in Oncology
Open Access
Published: Aug 2023
5 citations
5 citations
72 days after retraction
The Ins and Outs of Clusterin: Its Role in Cancer, Eye Diseases and Wound Healing
Christelle Gross, Louis-Philippe Guérin, Bianca G. Socol et al. (5 authors)
International Journal of Molecular Sciences
Open Access
Published: Aug 2023
8 citations
8 citations
66 days after retraction
Chemotherapy-induced exosomal circBACH1 promotes breast cancer resistance and stemness via miR-217/G3BP2 signaling pathway
Wenjie Xia, Wuzhen Chen, Chao Ni et al. (9 authors)
Breast Cancer Research
Open Access
Published: Jul 2023
24 citations
24 citations
28 days after retraction
STAT3 signaling in prostate cancer progression and therapy resistance: An oncogenic pathway with diverse functions
Mehrdokht Sadrkhanloo, Mahshid Deldar Abad Paskeh, Mehrdad Hashemi et al. (15 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Jan 2023
34 citations
34 citations
167 days before retraction
Clusterin is a biomarker of breast cancer prognosis and correlated with immune microenvironment
Ping Yang, Zhenyu Yang, Yanming Dong et al. (13 authors)
Translational Cancer Research
Open Access
Published: Jan 2023
14 citations
14 citations
169 days before retraction
CircWDR33 alleviates human pulmonary microvascular endothelial cell injury in sepsis-associated acute lung injury by targeting miR-217-5p/SERP1 axis
Ting You, Bihong Zhang
International Immunopharmacology
Published: Nov 2022
4 citations
4 citations
211 days before retraction
Circ_0002099 is a novel molecular therapeutic target for bladder cancer
Ping Fang, Jiang Qing-ling, Sizhong Liu et al. (6 authors)
Drug Development Research
Published: Oct 2022
10 citations
10 citations
235 days before retraction
The role and function of CLU in cancer biology and therapy
Yefei Zhang, Xiang Lv, Liming Chen et al. (4 authors)
Clinical and Experimental Medicine
Published: Sep 2022
21 citations
21 citations
279 days before retraction
Non-coding RNAs in EMT regulation: Association with tumor progression and therapy response
Mehrdokht Sadrkhanloo, Maliheh Entezari, Mohsen Rashidi et al. (11 authors)
European Journal of Pharmacology
Published: Aug 2022
13 citations
13 citations
293 days before retraction
Salidroside alleviates severe acute pancreatitis-triggered pancreatic injury and inflammation by regulating miR-217-5p/YAF2 axis
Xiaohong Wang, Jing Qian, Yun Meng et al. (8 authors)
International Immunopharmacology
Published: Aug 2022
6 citations
6 citations
313 days before retraction
DSCAM-AS1 Long Non-Coding RNA Exerts Oncogenic Functions in Endometrial Adenocarcinoma via Activation of a Tumor-Promoting Transcriptome Profile
Oliver Treeck, Florian Weber, Jürgen Fritsch et al. (7 authors)
Biomedicines
Open Access
Published: Jul 2022
4 citations
4 citations
336 days before retraction
Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Elena Okina et al. (15 authors)
Journal of Experimental & Clinical Cancer Research
Open Access
Published: Jul 2022
130 citations
130 citations
353 days before retraction
Upregulation of miR‐886 indicates poor prognosis and promotes tumour progression of prostate cancer
Bin Pan, Jie Yu, Xiaoli Liu
Andrologia
Open Access
Published: Nov 2021
9 citations
9 citations
579 days before retraction
Quick Stats
Total Citations:
14
Years Since Retraction:
2.4 years
Open Access:
Yes
Last Checked:
Jul 24, 2025